Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating

Craig-Hallum analyst Matt Hewitt maintains $Avid Bioservices(CDMO.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 42.7% and a total average return of -4.4% over

Moomoo NewsJul 16 09:34 ET · Ratings

Craig-Hallum Reaffirms Their Buy Rating on Avid Bioservices (CDMO)

TipRanksJul 16 08:58 ET

Avid Bioservices (NASDAQ:CDMO) Is Making Moderate Use Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it seems the smart

Simply Wall StJul 14 09:17 ET

KeyBanc Maintains Avid Bioservices(CDMO.US) With Buy Rating, Maintains Target Price $14

KeyBanc analyst Paul Knight maintains $Avid Bioservices(CDMO.US)$ with a buy rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 42.1% and a tot

Moomoo NewsJul 4 11:31 ET · Ratings

Why Avid Bioservices Stock Is Moving Higher Wednesday

Avid Bioservices, Inc. (NASDAQ:CDMO) shares are trading higher on Wednesday following the company reporting better-than-expected 2024 fiscal-year fourth quarter sales.The Details: Avid reported fourth

BenzingaJul 3 12:57 ET

Avid Bioservices Shares Rise on Upbeat FY25 Outlook

By Michael Susin Avid Bioservices shares rose on Wednesday after the group said it expects revenue to sharply increase in fiscal 2025 and to generate positive cashflow and despite posting a widened f

WSJJul 3 11:01 ET